Navigation Links
Bayer HealthCare Awards $2.5 Million to Advance Hemophilia Research and Improve Patient Care
Date:7/14/2009

h.D., associate professor and director, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, Calif., will address this issue by investigating why black hemophilia A patients are twice as likely as white patients to develop neutralizing antibodies (inhibitors) against replacement Factor VIII proteins. In another study, Early Career Investigator Award recipient Michael P. Horn, Ph.D., senior scientist, University Hospital of Bern, Bern, Switzerland, will investigate the influence an individual's immune system and specific factors have on the risk of inhibitor development.

"Through our support of research, clinical investigators, fellows in training and others, Bayer is helping to develop the next generation of hemophilia care and treatment professionals while supporting research that may lead to novel therapies," said John Murphy, Ph.D., member of the BHAP Grants, Review and Awards Committee and director, Molecular Biology, Protein Therapeutics, Bayer HealthCare. "These investments in basic research and patient services not only demonstrate our passion for advancing hemophilia treatment, but illustrate our ongoing commitment to the global hemophilia community."

Since 2002, BHAP has distributed more than $17.5 million through 157 research awards. Recipients from 27 countries have helped produce more than 80 abstracts and 60 papers to date.

Following are the 2009 award recipients for each of the BHAP categories:

Special Project Awards: Provide support for a wide range of scientific research in the field of hemophilia.

  • Tom Howard, Greater Los Angeles VA Healthcare System, USA
  • Maurizio Margaglione, University of Foggia, Italy
  • Gerry Nicolaes, Cardiovascular Research Institute Maastricht, The Netherlands
  • Gary Nelsestuen, University of Minnesota, Minneapolis, USA
  • Keiji Nogami, Nara
    '/>"/>

SOURCE Bayer HealthCare
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Bayer HealthCare Launches Hemophilia Self-Infusion Training Program
2. Bayer CropScience and Monsanto Sign Cross Licensing Agreement on Herbicide Tolerance Traits in Rapeseed/Canola
3. Bayer Diabetes Care Launches A1CNow(R) SELFCHECK, a New A1C Monitor for At-Home Use
4. Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
5. AUDIO from Medialink, Bayer Healthcare and Onyx Pharmaceuticals: Facts About Hepatitis
6. Bayer to Present Data on Development Compound BAY 73-4506 at 45th Annual Meeting of the American Society of Clinical Oncology
7. Now Available: Bayer Diabetes Cares CONTOUR(R) Meters in Midnight Blue and Orange Burst
8. Bayer CropScience Welcomes New Emergency Services Leader to the Institute Site
9. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
10. Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia
11. Nick Jonas and Bayer Diabetes Care Launch Creativity Contest to Encourage Kids With Diabetes to Express Their Simple Win
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... (PRWEB) July 22, 2014 The Beryl ... and third annual Institute Scholar Program. These offerings reinforce ... the patient experience in healthcare and the need for ... The grant and scholar programs are intended ... , Value of focusing on the patient experience ...
(Date:7/22/2014)... July 22, 2014 The market for ... past few years, owing to novel medical indications created ... in the aging societies where physical appearance is extremely ... one player, current competitors, new companies and technologies are ... biosimilar BoNTs will put the price of 1st-gen products ...
(Date:7/22/2014)... CarePoint Health is pleased to announce that ... of the medical staff at Bayonne Medical Center. The election ... as voted on by the physicians on staff. The office ... relation to the administration at Bayonne Medical Center. Dr. Levine ... work to make the Medical Center the best it can ...
(Date:7/22/2014)... The Middle East Drilling fluid and Completion fluid ... fluid market in Middle East with analysis and forecast of ... East is estimated to grow from around $560 million in ... 5.7%, for the given period. , Browse through the TOC ... report, to get an idea of the in-depth analysis provided. ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Over ... in almost every sphere of human anatomy. In ... forth advancements that rendered the possibility of deploying ... including blood and tissues, in order to detect ... congenital abnormality. Essentially, In-vitro Diagnostics (IVD) have earned ...
Breaking Medicine News(10 mins):Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4Health News:Dr. Howard Levine Elected President of the Medical Staff at Bayonne Medical Center 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Middle East Drilling Fluid & Completion Fluid Market is Expected to Reach $740 Million in 2018 - New Report by MicroMarket Monitor 6Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 2Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 3Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 4
... The medical community has repeatedly warned against plying young children with ... parents seem to care . Certainly not in Australia. ... extractions, dentists in that country say. ,In the ... but to remove all 20 baby teeth. ,"It's ...
... long ago there was a theory doing the rounds that ... autistic individual. This theory was not well received and ... prompted the proponents of the theory to associate the schemingly ... autism? ,Autism is a developmental disability that affects ...
... way for 70-year-old Hakimuddin of Orissa and his three ... after the impoverished man wrote to India's president ... district collector of Bhadrak in Orissa constituted a team ... on the condition of the poor family in Kamalpur ...
... common genetic variation on chromosome 9p21 is linked to a ... new international research study . The findings are published today ... an upcoming printed edition of the journal. ,Researchers ... of suffering a heart attack (myocardial infarction) and a 2.02-fold ...
... (CE-US) after a liver transplant is highly accurate in ... to a recent study. ,The study consisted ... exam after developing fluid in the abdomen and/or unclear ... serious complication in the early post transplant period, caused ...
... University researchers seem to know what makes certain babies prone ... Edinburgh University and the Royal Hospital for Sick Children in ... premature and small babies which expose them to risks of ... of the maternal and child health sciences division, are team ...
Cached Medicine News:Health News:Experts Call for Warning Lables on Fruit Juice to Save Kids' Teeth 2Health News:Diet for Autism 2Health News:Diet for Autism 3Health News:Disabled Orissa Brothers Lives Saved by Timely Intervention 2Health News:Genetic Variation is Linked to Substantial Risk in Heart Attack 2
(Date:7/22/2014)... -- BiologicTx ® today announced their participation in ... Donation transplant exchange utilizing BiologicTx,s proprietary matching software, Matchgrid™. ... the Miami Transplant Institute, located at Jackson Memorial Hospital ... Kidney Paired Donation (KPD) is an option for ... with one another due to incompatible blood types or ...
(Date:7/22/2014)...  PuraMed BioScience®, Inc., (OTCBB: PMBS), a researcher, ... healthcare products, announced today that the company is ... "We are pleased to sponsor Operation Troop ... Chairman of PuraMed BioScience. "Research shows that many ... migraines much more frequently than the general population. ...
(Date:7/22/2014)...  Neurotrope Bioscience, Inc., a subsidiary of Neurotrope, Inc. ... with the Icahn School of Medicine at ... ) to utilize its proprietary information and data package ... Niemann-Pick Type C Disease (NPC), a rare disease, mostly ... license also covers other diseases and disorders relying on ...
Breaking Medicine Technology:BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 2PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5
... 29, 2012  MedImmune today announced that the U.S. ... Quadrivalent (Influenza Vaccine Live, Intranasal) for prevention of ... the second quarter of last year.  FluMist Quadrivalent ... the FDA. All other currently available ...
... 29, 2012 Accuray Incorporated (Nasdaq: ... it has received the NorthFace ScoreBoard Award(SM) ... (Omega) in recognition of achieving excellence in customer service and ... customer satisfaction, Accuray is the first organization also to qualify ...
Cached Medicine Technology:MedImmune Announces FDA Approval of First Four-strain Flu Vaccine, FluMistĀ® Quadrivalent (Influenza Vaccine Live, Intranasal) 2MedImmune Announces FDA Approval of First Four-strain Flu Vaccine, FluMistĀ® Quadrivalent (Influenza Vaccine Live, Intranasal) 3Accuray Recognized for Delivering 'World-Class' Customer Service 2Accuray Recognized for Delivering 'World-Class' Customer Service 3Accuray Recognized for Delivering 'World-Class' Customer Service 4
The Perfect Single basic Vac Manifold is used to process a single 96-well plate; processing time is approximately 30 minutes....
... Perfect Single Vac Manifold is ... plate in 30 minutes; the ... "open/closed" switch and a vacuum ... operation. contains vacuum chamber, on/off ...
... automated alternative to Kuderna-Danish, Rotary, Vacuum-Style and Nitrogen Blow-Down Evaporators. For over ten years TurboVap concentration technology ... ... ... ...
Plastic Tray Type Vacuum Manifold...
Medicine Products: